ILLUMINA, INC. (ILMN)
Health Care / Life Sciences Tools & Services
S&P MidCap 400$126.70
Above average across most dimensions. A solid candidate.
Consider Buy
Score based on 5 of 5 models — high confidence
Is ILLUMINA, INC. a Good Investment in 2026?
ILLUMINA, INC. (ILMN) scores 7.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates ILLUMINA, INC. as Strong (7/9). However, the Graham model rates it Caution — 50% above fair value. ILLUMINA, INC. currently trades below its estimated fair value of $138, suggesting potential upside. ILLUMINA, INC. ranks #92 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading near or slightly below estimated fair value.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Attractive
Business quality & competitive moat
Graham
Caution
50% above fair value
Lynch
Attractive
PEG 0.9 · Fast Grower
Greenblatt
Neutral
Top half (rank 36%)
Frequently Asked Questions
Is ILLUMINA, INC. (ILMN) a good investment?
What is ILLUMINA, INC.'s Piotroski F-Score?
Is ILMN overvalued or undervalued?
How does ILMN compare to other Health Care stocks?
What do investment models say about ILMN?
Similar Stocks
Compare ILMN with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer